CSC Step-down intervention
OtherWeb-based telemedicine and a smartphone app, to decrease disengagement likelihood
NCT Number: NCT04005378
Maintaining treatment engagement is critical for first episode psychosis patients to experience gains possible with coordinated specialty care (CSC). This study is designed to identify CSC participants still receiving care but at high risk for disengagement and to intervene to prevent/delay disengagement.
Interested in participating?
Request Info15 year–40 year
All sexes
Interventional
Phase 4
Henderson Behavioral Health, Lauderdale Lakes, Florida, United States
In Phase 1 of the project, we will confirm a model predicting factors associated with later disengagement from CSC treatment. In Phase 2, we will compare disengagement among high-risk individuals with a CSC Step-down intervention to that with standard CSC care. The Step-down intervention will use web-based telemedicine and a smartphone app, to decrease disengagement likelihood. High-risk participants identified by predictors found in Phase 1 will be offered the intervention.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Web-based telemedicine and a smartphone app, to decrease disengagement likelihood
Usual Care provided by CSC center
Time frame: Minimum of 6 months
Rate of disengagement from CSC program
Contact information is provided by the study sponsor or research team.
Cristina Gonzalez, MS
CONTACT
Patricia Marcy, BSN
CONTACT
Northwell Health
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06774417
Clinical High Risk, Early Psychosis
New York, United States
View Trial DetailsNCT07122531
Acid-Base Imbalance, Acidosis
Sherbrooke, Quebec, Canada
View Trial DetailsNCT06774430
Clinical High Risk, Early Psychosis
New York, United States
View Trial DetailsNCT04889911
First Episode Psychosis, Youth
Indianapolis, Indiana, United States
View Trial Details